Pharmacy Focus

February 16, 2018

Assessing Novel Oral Anticoagulants

Newer medications for preventing and managing thromboembolic disorders directly target the enzymatic activity of thrombin and factor Xa, blocking the generation of fibrin clots.

Continuing Education

$6.97 Per CE Exam or $59 for 12 Lessons